Bayer is nearing the end of the road for glyphosate, executives say

Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.

Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.

More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.

Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.

Related Stories
A new study by the National Grains and Feeds Association found that their industry generates $401.7 billion in economic output and supports over 1.16 million jobs nationwide.
National Education Center for Ag Safety Director Dan Neenan joins us to discuss grain bin safety and the steps producers can take to prevent tragedies.
As National Advisor, Carson will counsel both President Trump and Secretary Rollins on nutrition, healthcare access in rural areas, and housing. He will also serve as a key member of the MAHA Commission.
Farmers should anticipate continued upward pressure on farm labor costs and monitor policy changes that may further impact hiring decisions.
Cotton farmers should weigh potential PLC payments against STAX coverage and act before the September 30 deadline.
What is it like working cattle with an outbreak of New World Screwworm so close to home? Wayne Cockrell, with the Texas and Southwestern Cattle Raisers Association, joined us on Wednesday to discuss.